Microsoft Word - DSU Degarelix FINAL sent to NICE - Biguanides - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2015-06-17 10:44:39 GnRH agonists Degarelix Prostate cancer Goserelin Antiandrogen Triptorelin Buserelin Ferring Pharmaceuticals Gonadotropin-releasing hormone agonist Prostate Management of prostate cancer Androgen deprivation therapy		Microsoft Word - DSU Degarelix FINAL sent to NICE Add to Reading List Source URL: www.nicedsu.org.uk Download Document from Source Website File Size: 194,14 KB Share Document on Facebook

	Microsoft Word - DSU Degarelix FINAL sent to NICE DocID: 1oZJA - View Document
	Sue Marty, Ph.D., D.A.B.T. The Dow Chemical Company TERA Endocrine Workshop April 23, 2013 Agenda DocID: 1gEI9 - View Document
	982. Local antiandrogen therapy, a novel treatment strategy for localized prostate cancer (LPC) C.B.2, Lennernäs, B.3, Tolf, A.T.4, Häggman, M.H.1, Ladjevardi, S.l.1, Ahlström, H.A.2, Von Below, Weis, J.W.2, Wa DocID: 1buBO - View Document
	Metabolomic Profiling Reveals a Role for Androgen in Activating Amino Acid Metabolism and Methylation in Prostate Cancer Cells Nagireddy Putluri1,2¤, Ali Shojaie5, Vihas T. Vasu1,2, Srilatha Nalluri1,2, Shaiju K. Vareed DocID: 178xd - View Document
	Compilation of Research on Occupational Exposure to Chemicals in Salons  Produced by the National Healthy Nail Salon Alliance  DocID: 16yYy - View Document